← Leaderboards
Weiming Xia
Edith Nourse Rogers Memorial Veterans Hospital
$5,297,314
Attributed
$6,727,425
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,727,425 · 7
VA$0 · 6
By mechanism
RF1$2,860,223 · 1
R01$2,715,321 · 2
P01$1,150,541 · 2
M01$1,340 · 2
I01$0 · 2
IS1$0 · 2
Top collaborators
- Peter Morin Morin5 shared
- Lee E Goldstein3 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainS DiseaseCellsProteinsTau ProteinsPlasmaNeuronsMouse ModelPathologyAmyloid Beta-ProteinNeurofibrillary TanglesTransgenic MicePositioning AttributeEnzyme-Linked Immunosorbent AssayResearch PersonnelPathway InteractionsSenile PlaquesBiologicalRegulationResourcesPathogenesisSmall MoleculeBiological Markers
Grant awards (32)
Big data and small molecules for Alzheimer's disease$801,219
R01 · FY2025 · AG · contact PI
Big data and small molecules for Alzheimer's disease$870,242
R01 · FY2024 · AG · contact PI
Exploring Alzheimer Therapeutics$0
I01 · FY2024 · VA · contact PI
Exploring Alzheimer Therapeutics$0
I01 · FY2023 · VA · contact PI
Exploring Alzheimer Therapeutics$0
I01 · FY2022 · VA · contact PI
Big data and small molecules for Alzheimer's disease$412,500
RF1 · FY2021 · AG · contact PI
Exploring Alzheimer Therapeutics$0
I01 · FY2021 · VA · contact PI
Profiling Alzheimer's Biomarkers$0
I01 · FY2021 · VA · contact PI
Big data and small molecules for Alzheimer's disease$412,500
RF1 · FY2020 · AG · contact PI
Profiling Alzheimer's Biomarkers$0
I01 · FY2020 · VA · contact PI
Exploring Alzheimer Therapeutics$0
I01 · FY2020 · VA · contact PI
Big data and small molecules for Alzheimer's disease$2,035,223
RF1 · FY2019 · AG · contact PI
Three dimensional neuronal model for Alzheimer's brain$0
I21 · FY2019 · VA · contact PI
ShEEP Request for Imaging Mass Spectrometry System$0
IS1 · FY2019 · VA · contact PI
Profiling Alzheimer's Biomarkers$0
I01 · FY2019 · VA · contact PI
Three dimensional neuronal model for Alzheimer's brain$0
I21 · FY2018 · VA · contact PI
Profiling Alzheimer's Biomarkers$0
I01 · FY2018 · VA · contact PI
ShEEP request for a Helios CyTOF MS$0
IS1 · FY2017 · VA · contact PI
iPSC for Neurodegenerative Diseases$0
I21 · FY2016 · VA · contact PI
iPSC for Neurodegenerative Diseases$0
I21 · FY2015 · VA · contact PI
Reagents, ELISA and y-secretase Assay Core$123,277
P01 · FY2012 · AG · contact PI
Reagents, ELISA and y-secretase Assay Core$222,995
P01 · FY2011 · AG · contact PI
Reagents, ELISA and y-secretase Assay Core$219,766
P01 · FY2010 · AG · contact PI
Reagents, ELISA and y-secretase Assay Core$177,366
P01 · FY2009 · AG · contact PI
Reagents, ELISA and y-secretase Assay Core$172,200
P01 · FY2008 · AG · contact PI
THE ROLE OF NEURAL STEM CELLS IN THE DEVELOPMENT OF HUMAN EPILEPSY$627
M01 · FY2008 · RR · contact PI
THE ROLE OF NEURAL STEM CELLS IN THE DEVELOPMENT OF HUMAN EPILEPSY$713
M01 · FY2007 · RR · contact PI
PRESENILINASE AND ITS RELATIONSHIP TO GAMMA SECRETASE$234,937
P01 · FY2006 · AG · contact PI
PRESENILIN ENDOPROTEASE &GAMMA-SECRETASE ACTIVITY$269,123
R01 · FY2003 · AG
PRESENILIN ENDOPROTEASE &GAMMA-SECRETASE ACTIVITY$261,283
R01 · FY2002 · AG
PRESENILIN ENDOPROTEASE &GAMMA-SECRETASE ACTIVITY$253,670
R01 · FY2001 · AG
PRESENILIN ENDOPROTEASE &GAMMA-SECRETASE ACTIVITY$259,784
R01 · FY2000 · AG